Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: A pilot study

Pharmacy World and Science

Volumn 26, Issue 5, 2004, Pages 282-288

  Fleming, Glenda F ^a   McElnay, James C ^b   Hughes, Carmel M ^b  

^a Research and Development Office   (Ireland)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Abuse; Community pharmacy; Harm minimisation; Medicine misuse; Non prescription products; Northern Ireland; Over the counter products

Indexed keywords

ANTIHISTAMINIC AGENT; COCODAMOL; KAOLIN; LAXATIVE; MORPHINE; NON PRESCRIPTION DRUG; OPIATE;

ARTICLE; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; DRUG ABUSE; DRUG MISUSE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MALE; OUTCOMES RESEARCH; PHARMACIST; THEORETICAL MODEL;

ALGORITHMS; COMMUNITY PHARMACY SERVICES; DRUGS, NON-PRESCRIPTION; HUMANS; MODELS, PSYCHOLOGICAL; PILOT PROJECTS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 4644220044     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000042891.66983.60     Document Type: Article

References (36)

1. Ball K, Wilde M. OTC medicines misuse in West Cumbria. Pharm J 1989; 242: 40.
2. Paxton R, Chapple P. Misuse of over-the-counter medicines: a survey in one English County. Pharm J 1996; 256: 313-5.
3. Hughes GF, McElnay JC, Hughes CM. Abuse/misuse of non-prescription drugs. Pharm World Sci 1999; 21: 251-5.
4. Kennedy M. Cardiac glycoside toxicity: an unusual manifestation of drug addiction. Med J Aust 1981; 2: 686-9.
5. Seow SSW. Abuse of APF linctus codeine and cardiac glycoside toxicity. Med J Aust 1984; 140: 54.
6. Thurston D, Taylor K. Gee's linctus. Pharm J 1984; 233: 63.
7. Mason AB, Pugh SE, Holt DW. Cardiac glycoside toxicity resulting from cough linctus abuse. Hum Toxicol 1987; 6: 251-2.
8. Barragry JM, Morris DV. Fatal dependence on kaolin and morphine mixture. Postgrad Med J 1980; 56: 180-1.
9. Eknoyan G. Current status of chronic analgesic and nonsteriodal anti-inflammatory drug nephropathy. Curr Opin Nephrol Hypertens 1994; 3: 182-8.
10. Noels LM, Elseviers MM, De Broe ME. Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium. Nephrol Dial Transplant 1995; 10: 167-74.
11. De Broe ME, Elseviers MM, Bengtsson U, Mihatsch MJ, Molzahn M, Pommer W et al. Analgesic nephropathy. Nephrol Dial Transplant 1996; 11: 2407-8.
12. Elseviers MM, De Broe ME. Analgesic nephropathy: is it cause by multi-analgesic abuse or single substance use? Drug Saf 1999; 20: 15-24.
13. Gott PH. Cyclizine toxicity - intentional drug abuse of a proprietary antihistamine. N Engl J Med 1968; 279: 596.
14. Bassett KE, Schunk JE, Insley Crouch B. Cyclizine abuse by teenagers in Utah. Am J Emerg Med 1996; 14 (5): 472-4.
15. Rowe C, Verjee Z, Koren G. Adolescence dimenhydrinate abuse: resurgence of an old problem. J Adolesc Health 1997; 21: 47-9.
16. Backer RC, McFeeley P, Wohlenberg N. Fatality resulting from cyclizine overdose. J Anal Toxicol 1989; 13: 308-9.
17. Clarke RF, Vance MV. Massive diphenhydramine poisoning resulting in a wide-complex tachycardia: successful treatment with sodium bicarbonate. Ann Emerg Med 1992; 21: 318-21.
18. Winn RE, McDonnell KP. Fatality secondary to massive overdose of dimenhydrinate. Ann Emerg Med 1993; 22: 1481-4.
19. Gardner DM, Kutcher S. Dimenhydrinate abuse among adolescents. Can J Psychiatry, 1993; 38: 113-6.
20. Brown JE, Sigmundson HK. Delirium from misuses of dimenhydrinate. Can Med Assoc J 1969; 101: 49-50.
21. Atkinson MK. Misuse of cyclizine. Pharm J 1985; 235: 773.
22. Moriarty KJ, Silk DBA. Laxative abuse. Digest Dis 1988; 6: 15-29.
23. Vanin JR, Saylor KE. Laxative abuse: a hazardous habit for weight control. College Health 1989; 37: 227-30.
24. Meyers AM, Feldman C, Sonnekus MI, Ninin DT, Margolius LP, Whalley NA. Chronic laxative abusers with pseudo-idiopathic oedema and autonomous pseudo-bartter's syndrome: a spectrum of metabolic madness, or new lights on an old disease? S Afr Med J 1990; 78: 631-6.
25. Muller-Lissner SA. Adverse effects of laxatives: fact and fiction. Pharmacology 1993; 47 (1 Suppl): 138-45.
26. Baker EH, Sandle GI. Complications of laxative abuse. Annu Rev Med 1996; 47: 127-34.
27. DerMarderosian A, Brudnicki SM. The misuse and abuse of OTC laxatives. Am Druggist 1996; 213(1): 49-55.
28. Wright LF, DuVal JW. Renal injury associated with laxative abuse. South Med J 1987; 80: 1304-6.
29. Copeland PM. Renal failure associated with laxative abuse. Psychother Psychosom 1994; 62: 200-2.
30. Krupski J, Pincus KT. Laxative induces nephropathy: a case report. J Pharmacoepidemiology 1996; 5 (1): 39-44.
31. Pharmaceutical Society of Northern Ireland. Ethics and Practice: A Guide for Pharmacists in Northern Ireland. 1997 edition. Belfast: Pharmaceutical Society of Northern Ireland 1997: 34-6.
32. Temple DJ. Harm-reduction. Chemist Druggist 1996; 245: 730-1.
33. De Almeida Neto AC, Benrimoj SI, Gomel M, Fois R. Inappropriate self-medication practices: a pharmacy based intervention. J Soc Admin Pharm 1996; 13: 131-8.
34. Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behaviour. London: The Guildford Press 1991.
35. Prochaska JO, DiClemente CC. The transtheoretical approach: crossing traditional boundaries of therapy. Illinois: Dow Jones-Irwin, 1984.
36. Ware Jr J, Snow K, Kosinski M, Gandek B. SF36 health survey. Manual and interpretation guide. Boston: Nimrod Press, 1993.